ArticleDigestive diseases and sciences2010
Race and inflammatory bowel disease in an urban healthcare system.
Article in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.
- Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis.BMC public health · 2024Pooled it
- Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.Digestive diseases and sciences · 2018Pooled it
- Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.Inflammatory bowel diseases · 2013Pooled it
- Epidemiology and clinical outcomes of hospitalized Hispanic patients with IBD: results of a large national cohort study.International journal of colorectal disease · 2025Article
- Differential Manifestations of Inflammatory Bowel Disease Based on Race and Immigration Status.Gastro hep advances · 2024Article
- Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011-2020.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022Article
- Evaluation of Racial/Ethnic Disparities in the Surgical Management of Inflammatory Bowel Disease.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022Article
- AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.Gastroenterology · 2021Review
- Epidemiology of Ocular Manifestations in Autoimmune Disease.Frontiers in immunology · 2021Review
- Article
- Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations.Japanese journal of gastroenterology and hepatology · 2020Article
- Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.Digestive diseases and sciences · 2017Article
- African Americans and Short-Term Outcomes after Surgery for Crohn's Disease: An ACS-NSQIP Analysis.Journal of Crohn's & colitis · 2017Article
- Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease.Clinical and experimental gastroenterology · 2017Article
- Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease.Digestive diseases and sciences · 2016Article
- Racial disparities in readmission, complications, and procedures in children with Crohn's disease.Inflammatory bowel diseases · 2015Article
- Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.World journal of gastroenterology · 2015Article
- Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.Digestive diseases and sciences · 2014Article
- A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients.International journal of colorectal disease · 2014Article
- On the question of ethnicity and its impact on IBD-related outcomes.Digestive diseases and sciences · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundInflammatory bowel disease (IBD) is increasingly common among non-Caucasian populations, but interracial differences in disease characteristics and management are not well-characterized.
aimsWe tested the hypothesis that disease characteristics and management vary by race among IBD patients in an ethnically diverse healthcare system.
methodsA retrospective study of the safety net healthcare system of San Francisco, CA, from 1996 to 2009 was undertaken. Patient records with International Classification of Diseases, 9th Revision (ICD9) codes 555.xx, 556.xx, and 558.xx were reviewed. Adult patients with confirmed IBD diagnoses were included. Interracial variations in disease characteristics and management were assessed broadly; focused between-race comparisons identified specific differences.
resultsThe 228 subjects included 77 (33.4%) with Crohn's disease (CD), 150 (65.8%) with ulcerative colitis, and 1 (0.4%) with IBD, type unclassified. The race distribution included 105 (46.1%) white, 34 (14.9%) black, 35 (15.4%) Hispanic, and 51 (22.4%) Asian subjects. Asians and Hispanics were diagnosed at older ages (41.0 and 37.1 years, respectively) and had shorter disease durations (5.4 and 5.2 years, respectively) than whites (30.5 years at diagnosis and 8.6 years duration, P < 0.05) and blacks (31.7 years at diagnosis and 12.1 years duration, P < 0.05). CD was more common among blacks (50% of subjects) than Asians (25.5% of subjects, P = 0.015). The Montreal classification of IBD was similar among races. Hispanics were less likely than others to be treated with 5-aminosalicylates (5-ASA), immunomodulators, and steroids. Medical and surgical management was otherwise similar among races.
conclusionsModest race-based differences in IBD characteristics exist in this racially diverse healthcare system, but the management of IBD is similar among race groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.